Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market Ad hoc announcement pursuant to...
Sandoz launches Hyrimoz® (adalimumab) high-concentration formulation in Europe, aiming to improve patient care Biosimilar Hyrimoz®...
Sandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in Germany Investment of EUR 175 million...
Sandoz successfully issues EUR 2.0 billion inaugural Eurobonds NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN ...
Sandoz successfully issues CHF 750 million in inaugural bonds Highly successful inaugural CHF senior bonds priced earlier todayTwo tranches...
Sandoz reports year-to-date sales for the first nine months of 2023 Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.